JWH-210 Wikipedia - Revision history

ISZCindy643869 at 19:19, 28 May 2026

2026-05-28T19:19:48Z

StarlaSaldana91 at 19:14, 28 May 2026

2026-05-28T19:14:32Z

StarlaSaldana91 at 19:13, 28 May 2026

2026-05-28T19:13:37Z

StarlaSaldana91 at 19:07, 28 May 2026

2026-05-28T19:07:05Z

CasimiraVangundy: Created page with "As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by com..."

2026-05-28T06:59:40Z

Created page with "As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by com..."

New page

As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose-dependent manner. A total of 5 mice in the JWH-081 (5 mg/kg, i.p.) treated group and 6 mice in the 5CLADBA JWH-210 (5 mg/kg, i.p.) treated group showed loss of traction, of which 4 and 5 showed tremor, respectively. Memory retention was measured after the memory acquisition was tested as a probe trial. About Powder JWH-2 Figure 1. Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporis All of the compounds tested in the present study depressed locomotor activity as is typical for other synthetic cannabinoids (see review by Wiley et al., 2017). Average horizontal activity counts/10 min as a function of time (10 min bins) and dose. Depressant effects of 1.33 mg/kg were observed within 10 min following administration and peak depressant effects were [https://cannabinoidsrc4f-adb.com/ 5CLADBA] observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017 Fig. 2. Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender 5CLADBA and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite. Victim B also brought "something resembling a drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur

← Older revision		Revision as of 19:19, 28 May 2026
Line 1:		Line 1:
−	~~The chemical structures~~ of ~~the recent synthetic cannabinoids are unlike that~~ of ~~Δ9-THC, but are largely based on~~ the ~~structure of~~ older synthetic cannabinoids that are ~~known~~ to ~~have substantial abuse liability~~ (~~Fig~~. 1<br><br><br>In the ~~present study~~, ~~we performed various methods based on animal behavioral testing~~ including ~~FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water~~-~~maze~~ test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed ~~to confirm~~ the ~~possibility~~ of ~~neurotoxicity~~ of ~~the tested substances by hematoxylin~~ and ~~eosin staining method~~ from ~~collected brain samples. In the present study~~, ~~we evaluated~~ the ~~neurotoxicity~~ of ~~two synthetic cannabinoids (JWH-081~~ and ~~JWH~~-~~210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice~~ with ~~various doses (0.1~~, 1, ~~5 mg/kg). Selecting powder JWH-210 demands careful evaluation~~ of ~~purity, legality, and supplier credibility~~. ~~Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc~~<br><br>~~<br>Due to~~ the ~~unknown toxicity of newly emerging SCRAs~~, ~~forensic assessments of cases involving these substances are challenging~~. ~~According to the reported cases~~ and ~~reviews~~ of ~~the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F~~-~~MDMB-BINACA~~ in the ~~postmortem blood was 2.50 and 2.34 ng/mL, and blood alcohol concentration was 2~~.~~11 and 2.49 g/L, respectively. Two fatal cases are reported caused by simultaneous consumption of 4F~~-~~MDMB~~-~~BINACA~~ and ~~ethanol.<br>Fig. 2. <br>The precursor ion m/z 396~~ (~~B10, B12/B15~~) ~~was 32 Da higher than~~ the ~~parent drug, 4F~~-~~MDMB~~-~~BINACA, suggesting~~ the addition of two hydroxy groups. All the below explanations for transformations into metabolites are based on the data shown in Fig. Metabolites were identified according to their precursor ions, product ions, and ~~fragmentation patterns~~ (Fig. 1). ~~Traditional in~~-~~vivo metabolism studies~~ to ~~generate human metabolites of drugs relied heavily on the use of whole animal model systems, which are expensive, limited by~~ drug ~~administration amount~~, ~~influenced by species variation and faced by many ethical issues. Eight in-vivo metabolites tentatively identified were mainly products~~ of ~~ester hydrolysis with or without additional dehydrogenation, N~~-~~dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid.<br>Fig. 1. <br>Monitoring metabolism of synthetic cannabinoid 4F~~-~~MDMB~~-~~BINACA via high~~-~~resolution~~ mass spectrometry ~~assessed in cultured hepatoma cell line, fungus, [https://cannabinoidsrc4f~~-adb.com/ visit this link] liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the ~~reported cases) of SCRA and 1~~.~~5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest~~ a ~~possible synergistic effect between SCRAs~~ and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at ~~low or moderate ethanol doses [29~~, ~~30], but no data on high doses~~ of ~~ethanol are available. Given that THC~~ and ~~ethanol act on~~ the ~~same receptors, data on their simultaneous use may yield important insights in this regard.~~<br>~~Fungus C. elegans~~ <br>~~Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3~~,~~3-dimethylbutanoate~~ (~~4F-MDMB-BINACA~~, ~~4F-MDMB-BUTINACA or 4F-ADB~~)~~, found in numerous SCB product seizures, has been reported by various law enforcement since 2018~~ . However, ~~most~~ of ~~the SCBs are full agonists at CB1 and CB2 receptors~~, ~~having~~ a ~~higher risk of undesirable side effects when compared~~ to ~~THC which is a partial agonist~~ . ~~Synthetic cannabinoids (SCBs)~~ are ~~agonists at cannabinoid receptor type 1~~ (~~CB1)~~ and ~~type 2 (CB2)~~, ~~where they elicit their main effect~~<br><br><br>~~A total of 2 and 3 methamphetamine treated mice fell from~~ the ~~spinning rod 30 min~~ and ~~2 hr after the administration, respectively~~. ~~After~~ the ~~first injection, 6 mice~~ of ~~the positive control group~~ (~~methamphetamine~~, ~~5 mg/kg~~, i.p.~~) showed loss of traction~~, of ~~which 4 showed tremor. Most~~ of ~~the abnormalities were normalized in~~ synthetic ~~cannabinoid treated mice although~~ those ~~abnormal behaviors remained~~ in ~~methamphetamine treated animals after 2 hr~~ of ~~administration. Brain samples~~ were ~~prepared from the mice after the last administration of test substance~~<br><br><br>~~In general~~, ~~the locomotor depressant and discriminative stimulus effects visit this link~~ have ~~been observed at doses~~ that do not ~~produce adverse effects, although tremors were observed upon handling in mice~~ that ~~received JWH~~-~~210~~ (~~Gatch et al.~~, ~~2016~~), and 5F-~~AMB produced sustained vocalization and convulsions~~ in ~~rats (Gatch et al.~~, ~~2018)~~. ~~All~~ of ~~the synthetic cannabinoids tested in~~ the present study ~~fully substituted for~~ the ~~discriminative stimulus effects~~ of Δ9-~~THC. Subsequently~~, ~~a one~~-~~way analysis of variance was conducted on horizontal activity counts for the 30~~-~~min period of maximal effect~~, and ~~planned comparisons were conducted for each dose against the vehicle control using single degree-of~~-~~freedom F tests~~. ~~A two~~-~~way analysis of variance,~~ with ~~dose as~~ a ~~between groups factor~~ and ~~time as a within subject factor, was conducted on horizontal activity counts/10 min interval.<br>Michael B Gatch <br>These findings~~ are in ~~agreement with earlier studies showing~~ the ~~synthetic cannabinoids substitute for the discriminative stimulus~~ effects of ~~Δ9-THC~~ (~~see review by Wiley~~ et al.~~, 2017~~). ~~Pretreatment times and dose ranges for the drug discrimination assay were selected~~ based on ~~the time of peak depression in the locomotor activity assay in mice. As mentioned previously~~, ~~short-onset compounds have a greater abuse liability; further~~, ~~compounds that have fewer adverse effects while they are active are likely to be preferred. All five~~ of ~~the compounds in the present study fully substituted with a pretreatment time of 15 min~~, ~~suggesting a rapid onset of the discriminative stimulus~~ effects~~. All of the cathinones fully substituted for the discriminative stimulus effects of Δ9-tetrahydrocannabinol~~ (~~≥80% drug-appropriate responding~~). Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun	+	One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the [https://cannabinoidsrc4f-adb.com/ 4F ADB] presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom<br><br><br>Briefly, the FOB test was comprised of several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and death. The FOB test was performed using published procedures (Moser et al., 1989) with some modifications. However, because of their subjective properties, it is necessary to set up a more objective automated measurement to determine their neurotoxicity. However, there are only a couple of anecdotal reports suspecting the possibility of their neurotoxicity with no scientific evidence (Cohen et al., 2012; McGuinness and Newell, 2012; Harris and Brown, 2013; Hermanns et al., 2013<br><br><br>Morris water maze test was performed to evaluate the changes in learning and memory function. Only a few case reports about the dangers of some synthetic cannabinoids due to neurotoxicity have been published (Cohen et al., 2012; McGuinness et al., 2012; Harris and Brown, 2013; Hermanns et al., 2013). In addition, the lack of information about neurotoxicity of synthetic cannabinoids could allow abusers consume those substances undiscerningly. However, slight structural changes might cause biochemical properties including dependence liability and neurotoxicity. The substances used in the present study both possess naphthoylindole moiety as their parental structure. (B) The ratio of damaged cells containing pyknotic or condensed nuclei and low hematoxilin affinity to total cells were calculated in nucleus accumben<br><br><br>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali<br><br>4. Drugs <br>The purpose of the present study was to assess the abuse liability of 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA. The findings produce an apparent paradox, since CPP and self-administration predict with high reliability the likelihood that a compound will be abused by humans, and cannabinoids are well-known to produce active drug-seeking in humans. Drug discrimination is a well-known animal model of the subjective effects of drugs and correlates well with abuse liability (Young 2009; Horton et al. 2013). Assessment of abuse liability is based on several factors, including chemical structure, pharmacological mechanism of action, and finally, subjective and reinforcing behavioral effects (FDA, 2010; Swedberg, 2013).<br>Michael B Gat<br><br>Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun

← Older revision		Revision as of 19:14, 28 May 2026
Line 1:		Line 1:
−	~~Similarly, precursor ion identified at m/z 380 (B19/B21, B23/B25) was 16 Da higher than~~ the 4F-MDMB-BINACA, indicating monohydroxylation at the butyl side chain (B19/B21) and indazole (B23/B25) moieties with product ions m/z 145 and 161, respectively. Metabolites identified at m/z 366 (B8, B9, B13), which was 16 Da higher than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), confirmed monohydroxylation upon ester hydrolysis. Death involving these drugs have been reported [5,6,7,8,9], and this raises public health and social concerns. Due to their similar physiological effects to the principal psychoactive component of ~~cannabis,~~ Δ9-~~tetrahydrocannabinol (~~THC), ~~SCBs~~ are ~~gaining popularity and are often abused as recreational drugs. The fact that similar 4F-MDMB-BINACA and ethanol concentrations were detected in~~ the ~~postmortem blood samples~~ of ~~both victims suggests~~ that ~~both substances played a role in the fatal outcom<br><br>In general, the locomotor depressant and discriminative stimulus effects~~ have ~~been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210~~ (~~Gatch et al~~.~~, 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018~~<br><br>~~Fig. 2.~~ <br>~~Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L~~, ~~respectively). Forensic autopsy of both victims was~~ performed ~~four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe~~ on ~~medico~~-~~legal autopsies~~. ~~Elegans demonstrated the ability to form all of the in-vivo metabolites~~ and ~~has the potential to be used as a complementary model to predict and characterize human metabolites~~, ~~as well as identifying possible drug toxicities~~ for ~~emerging SCBs~~. ~~Thus~~, ~~identification of the relevant urinary markers~~ was ~~based primarily upon~~ the ~~prevalence~~ of ~~the in-vivo metabolites instead~~ of the ~~metabolites ranking that was based upon % peak area abundance ratio~~. ~~Moreover~~, ~~genetic makeup, physiological conditions~~ (~~age, gender~~ JWH-210 ~~powder and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity~~) ~~would further complicate the metabolism~~ of ~~drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity~~ and ~~matrix effects bias for each metabolite.<br>Data concerning the combined effects~~ of ~~SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level~~ (0~~.37–4~~.1 ~~ng/mL according to the reported cases) in cases in which~~ 1~~.5–2.~~5 g/~~L of ethanol is present in the blood~~. ~~The victims were brothers who were both found deceased after consuming 4F~~-~~MDMB-BINACA~~ and ~~ethanol~~. ~~These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F~~-~~MDMB~~-~~BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line~~, ~~fungus~~, ~~liver microsomes~~ and ~~confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author~~<br><br><br>~~Product ions detected at m/z 302, 217, and 145 (B2) confirmed that tert-leucine and indazole moieties remained unchanged, leading~~ to the ~~structure elucidation~~ of ~~a hydroxy-functional group at the 4-position~~ of the ~~butyl side chain by oxidative defluorination. The product ion m/z 336 (loss~~ of ~~methyl ester moiety) further confirmed~~ the ~~presence of dihydroxylated metabolites. The precursor ion~~, ~~m/z 364 (B14, B5/B6) had a loss~~ of ~~2 Da from m/z 366 indicated further dehydrogenation of the ester hydrolysis plus monohydroxylated metabolites~~. The ~~presence~~ of ~~the product ion m/z 320, likely formed from a loss of carbon dioxide, indicated monohydroxylation at the tert~~-~~leucine~~ in ~~B8 (m~~/~~z 219)~~, ~~butyl side chain in B9 (m/z 145)~~ and ~~indazole moiety in B13 (m~~/~~z 161)~~. ~~The precursor ion, m/z 350 showed a loss of 14 Da explaining the hydrolysis~~ of ~~methyl ester from~~ 4F-MDMB-BINACA.<br>Fig. 2. <br>~~4F-MDMB-BINACA~~ was ~~hydrolysed via ester hydrolysis forming~~ the 4F-MDMB-BINACA ~~ester hydrolysis metabolite (B22)~~. ~~Data obtained from~~ the ~~twenty urine samples were retrospectively analysed and processed using TraceFinder software~~ based on the ~~identification criteria of mass errors less than ± 5 ppm for full MS peaks~~ and ~~MS/MS peaks from the theoretical mass and matching of MS/MS spectra~~. ~~The mixture was vortex~~-~~mixed and 500 µL~~ of ~~this mixture and 500 µL~~ of ~~methanol were loaded onto the Clean Screen FASt® tube. After incubation~~, ~~the mixture was cooled at room temperature~~, and ~~150 µL of purified water was added~~. ~~High~~-~~resolution QTOF-MS data~~ were ~~acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer (Agilent Technologies) equipped~~ with ~~dual electrospray ionization (ESI) source operated in both positive and negative ion modes~~, ~~to determine accurate masses of the metabolites. Chromatographic separation was performed on an Agilent 1290 LC system with a Poroshell 120 EC~~-~~C18 analytical column (2.7 μm~~, ~~75 × 2.1 mm; Agilent Technologies, Santa Clara, CA, USA)~~.<br>Fig. 1. <br>~~This outcome was anticipated since CES~~-~~mediated hydrolysis is commonly~~ [https://cannabinoidsrc4f-adb.com/ ~~JWH-210 powder~~] ~~reported~~ as ~~the major metabolic pathway among the SCBs impacting the terminal ester group~~ . ~~Glucosides and sulfate metabolites have been reported with other SCBs where C~~. ~~From these three samples, sample 2 contained only an ester hydrolysis metabolite (m~~/~~z 350~~). ~~Both ester hydrolysis followed by oxidative defluorination to butanoic acid (B4, m~~/~~z 362)~~ and ~~monohydroxylation at tert-leucine moiety (B8~~, ~~m/z 366) metabolites were found in 16/20 urine samples (Table 2)~~. ~~A In~~-~~vitro metabolites observed in common among respective seven most abundant metabolites in b C~~. ~~The product ion detected~~ at ~~m/z 235~~, ~~indicating loss of sulfate~~, ~~confirmed the identity~~ of the ~~sulfation metabolite~~.<br>Fungus C. elegans <br>Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect	+	The chemical structures of the recent synthetic cannabinoids are unlike that of Δ9-THC, but are largely based on the structure of older synthetic cannabinoids that are known to have substantial abuse liability (Fig. 1<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc<br><br><br>Due to the unknown toxicity of newly emerging SCRAs, forensic assessments of cases involving these substances are challenging. According to the reported cases and reviews of the scientific literature, concurrent ethanol consumption should amplify the toxicity of SCRAs. The concentration of 4F-MDMB-BINACA in the postmortem blood was 2.50 and 2.34 ng/mL, and blood alcohol concentration was 2.11 and 2.49 g/L, respectively. Two fatal cases are reported caused by simultaneous consumption of 4F-MDMB-BINACA and ethanol.<br>Fig. 2. <br>The precursor ion m/z 396 (B10, B12/B15) was 32 Da higher than the parent drug, 4F-MDMB-BINACA, suggesting the addition of two hydroxy groups. All the below explanations for transformations into metabolites are based on the data shown in Fig. Metabolites were identified according to their precursor ions, product ions, and fragmentation patterns (Fig. 1). Traditional in-vivo metabolism studies to generate human metabolites of drugs relied heavily on the use of whole animal model systems, which are expensive, limited by drug administration amount, influenced by species variation and faced by many ethical issues. Eight in-vivo metabolites tentatively identified were mainly products of ester hydrolysis with or without additional dehydrogenation, N-dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid.<br>Fig. 1. <br>Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, [https://cannabinoidsrc4f-adb.com/ visit this link] liver microsomes and confirmed using urine samples The threshold for fatal overdose of combined use of SCRAs and ethanol can be estimated as a little ng/mL (0.37–4.1 ng/mL according to the reported cases) of SCRA and 1.5–2.5 g/L of ethanol. The reported cases and reviews of the scientific literature suggest a possible synergistic effect between SCRAs and ethanol, because their combined use clearly increases their toxicity. The victim died due to severe necrotizing pancreatitis and acute kidney injury evolving into multi-organ failure 11 days after hospital admission . Studies have found no unequivocal synergistic effect between THC and ethanol at low or moderate ethanol doses [29, 30], but no data on high doses of ethanol are available. Given that THC and ethanol act on the same receptors, data on their simultaneous use may yield important insights in this regard.<br>Fungus C. elegans <br>Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect<br><br><br>A total of 2 and 3 methamphetamine treated mice fell from the spinning rod 30 min and 2 hr after the administration, respectively. After the first injection, 6 mice of the positive control group (methamphetamine, 5 mg/kg, i.p.) showed loss of traction, of which 4 showed tremor. Most of the abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples were prepared from the mice after the last administration of test substance<br><br><br>In general, the locomotor depressant and discriminative stimulus effects visit this link have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval.<br>Michael B Gatch <br>These findings are in agreement with earlier studies showing the synthetic cannabinoids substitute for the discriminative stimulus effects of Δ9-THC (see review by Wiley et al., 2017). Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. As mentioned previously, short-onset compounds have a greater abuse liability; further, compounds that have fewer adverse effects while they are active are likely to be preferred. All five of the compounds in the present study fully substituted with a pretreatment time of 15 min, suggesting a rapid onset of the discriminative stimulus effects. All of the cathinones fully substituted for the discriminative stimulus effects of Δ9-tetrahydrocannabinol (≥80% drug-appropriate responding). Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun

← Older revision		Revision as of 19:13, 28 May 2026
Line 1:		Line 1:
−	~~High resolution mass spectrometry such as LC~~-~~QTOF~~-~~MS allows~~ the ~~detection~~ and ~~identification of a broad spectrum of recreational drugs~~, ~~including new psychoactive substances~~. ~~A point-of-care drugs of abuse~~ (~~DOA~~) ~~test~~ was ~~initially performed on~~ the ~~urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e~~-~~cigarette from Gaziantep~~, ~~Turkey 10 seconds before the onset of his first symptoms~~. ~~He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific~~, ~~transient symptoms~~, ~~clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms~~, ~~demonstrating the 5CLADBA presence~~ and ~~elution profiles of nicotine~~ and ~~ADB-BUTINACA in~~ the ~~analysed vape liquid sample. LC-QTOF~~-~~MS Chromatograms of Nicotine~~ (~~Top~~) and ~~ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient~~. The LC-~~QTOF~~-~~MS analysis showed that the e-liquid contained nicotine~~ and ~~ADB-BUTINACA (Fig. 1). Because~~ the ~~point-~~of~~-care DOA test is generally not able to detect synthetic recreational drug~~ substances~~, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating~~ a ~~light meal and drinking caffeinated sports drinks at~~ the ~~ER, the nausea complaints of the patient were reduced and the patient was discharged hom~~<br><br>~~<br>The same procedure was then applied to~~ the mice ~~once every day for 5 days~~. It was considered as coordination disturbance when mice fell from the test apparatus within 2 min. Mice that remained their position on the running apparatus at 10 rpm for at least 2 min were selected for further evaluation.~~<br>Table of Conten~~<br><br><br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender ~~[https://cannabinoidsrc4f~~-~~adb.com/ 5CLADBA]~~ and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author<br><br><br>~~As synthetic cannabinoid receptor agonists~~ (~~SCRA~~) ~~are gaining popularity globally~~, ~~clinicians have~~ to ~~understand that intoxication caused by vaping SCRA is not detected~~ by ~~commonly available tests~~. ~~He confirmed that he had been vaping an electronic cigarette~~ (~~e-cigarette~~) ~~earlier that day just before~~ the ~~onset~~ of ~~his symptoms~~. ~~Metabolic acidosis~~ (~~1/3~~, 0/7) ~~and respiratory acidosis~~ (1/3, 0/7)~~, All 10 patients recovered with supportive care, including intubation~~ and ~~ventilation for one case~~. ~~In 3 cases ADB-BUTINACA was~~ the ~~only substance detected, while in seven other substances~~ of ~~misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali~~<br><br>~~Legal status <br>Briefly,~~ the ~~FOB test~~ was ~~comprised~~ of ~~several behavioral changes including catalepsy~~, ~~traction~~, ~~tremor~~, ~~convulsion~~, ~~exopthalmos~~, ~~piloerection~~, ~~salivation~~, ~~lacrimation~~, ~~diarrhea~~, ~~skin coloration~~, ~~pinna reflex~~, ~~righting reflex~~, ~~and death~~. ~~The FOB test was performed using published procedures~~ (~~Moser et al.~~, ~~1989~~) ~~with some modifications~~. However, ~~because~~ of ~~their subjective properties~~, it is ~~necessary to set up~~ a ~~more objective automated measurement to determine their neurotoxicity~~. ~~However, there~~ are ~~only a couple of anecdotal reports suspecting the possibility of their neurotoxicity with no scientific evidence~~ (~~Cohen et al., 2012; McGuinness~~ and ~~Newell~~, ~~2012; Harris and Brown, 2013; Hermanns et al., 2013~~	+	Similarly, precursor ion identified at m/z 380 (B19/B21, B23/B25) was 16 Da higher than the 4F-MDMB-BINACA, indicating monohydroxylation at the butyl side chain (B19/B21) and indazole (B23/B25) moieties with product ions m/z 145 and 161, respectively. Metabolites identified at m/z 366 (B8, B9, B13), which was 16 Da higher than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), confirmed monohydroxylation upon ester hydrolysis. Death involving these drugs have been reported [5,6,7,8,9], and this raises public health and social concerns. Due to their similar physiological effects to the principal psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), SCBs are gaining popularity and are often abused as recreational drugs. The fact that similar 4F-MDMB-BINACA and ethanol concentrations were detected in the postmortem blood samples of both victims suggests that both substances played a role in the fatal outcom<br><br>In general, the locomotor depressant and discriminative stimulus effects have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018<br><br>Fig. 2. <br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender JWH-210 powder and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author<br><br><br>Product ions detected at m/z 302, 217, and 145 (B2) confirmed that tert-leucine and indazole moieties remained unchanged, leading to the structure elucidation of a hydroxy-functional group at the 4-position of the butyl side chain by oxidative defluorination. The product ion m/z 336 (loss of methyl ester moiety) further confirmed the presence of dihydroxylated metabolites. The precursor ion, m/z 364 (B14, B5/B6) had a loss of 2 Da from m/z 366 indicated further dehydrogenation of the ester hydrolysis plus monohydroxylated metabolites. The presence of the product ion m/z 320, likely formed from a loss of carbon dioxide, indicated monohydroxylation at the tert-leucine in B8 (m/z 219), butyl side chain in B9 (m/z 145) and indazole moiety in B13 (m/z 161). The precursor ion, m/z 350 showed a loss of 14 Da explaining the hydrolysis of methyl ester from 4F-MDMB-BINACA.<br>Fig. 2. <br>4F-MDMB-BINACA was hydrolysed via ester hydrolysis forming the 4F-MDMB-BINACA ester hydrolysis metabolite (B22). Data obtained from the twenty urine samples were retrospectively analysed and processed using TraceFinder software based on the identification criteria of mass errors less than ± 5 ppm for full MS peaks and MS/MS peaks from the theoretical mass and matching of MS/MS spectra. The mixture was vortex-mixed and 500 µL of this mixture and 500 µL of methanol were loaded onto the Clean Screen FASt® tube. After incubation, the mixture was cooled at room temperature, and 150 µL of purified water was added. High-resolution QTOF-MS data were acquired on an Agilent 6510 Accurate Mass QTOF mass spectrometer (Agilent Technologies) equipped with dual electrospray ionization (ESI) source operated in both positive and negative ion modes, to determine accurate masses of the metabolites. Chromatographic separation was performed on an Agilent 1290 LC system with a Poroshell 120 EC-C18 analytical column (2.7 μm, 75 × 2.1 mm; Agilent Technologies, Santa Clara, CA, USA).<br>Fig. 1. <br>This outcome was anticipated since CES-mediated hydrolysis is commonly [https://cannabinoidsrc4f-adb.com/ JWH-210 powder] reported as the major metabolic pathway among the SCBs impacting the terminal ester group . Glucosides and sulfate metabolites have been reported with other SCBs where C. From these three samples, sample 2 contained only an ester hydrolysis metabolite (m/z 350). Both ester hydrolysis followed by oxidative defluorination to butanoic acid (B4, m/z 362) and monohydroxylation at tert-leucine moiety (B8, m/z 366) metabolites were found in 16/20 urine samples (Table 2). A In-vitro metabolites observed in common among respective seven most abundant metabolites in b C. The product ion detected at m/z 235, indicating loss of sulfate, confirmed the identity of the sulfation metabolite.<br>Fungus C. elegans <br>Methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB), found in numerous SCB product seizures, has been reported by various law enforcement since 2018 . However, most of the SCBs are full agonists at CB1 and CB2 receptors, having a higher risk of undesirable side effects when compared to THC which is a partial agonist . Synthetic cannabinoids (SCBs) are agonists at cannabinoid receptor type 1 (CB1) and type 2 (CB2), where they elicit their main effect

← Older revision		Revision as of 19:07, 28 May 2026
Line 1:		Line 1:
−	~~As synthetic cannabinoid receptor agonists~~ (~~SCRA~~) ~~are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests~~. He confirmed ~~that he had been vaping~~ an ~~electronic cigarette (~~e-cigarette~~) earlier that day just~~ before the onset of his symptoms. ~~Metabolic acidosis (1/3, 0/7)~~ and ~~respiratory acidosis (1/3, 0/7), All 10 patients recovered~~ with ~~supportive care~~, ~~including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected~~, ~~while in seven other substances~~ of ~~misuse were also detected including other~~ SCRA~~, opioids, benzodiazepines cocaine and pregabali~~<br><br>~~<br>Observation item 1st injection 2nd injection 3rd injection 4th injection 5th injection Con. All groups treated with tested synthetic cannabinoids showed decreased weight gain rate in a dose~~-~~dependent manner. A total of 5 mice~~ in the ~~JWH~~-~~081~~ (~~5 mg/kg, i.p.~~) ~~treated group~~ and ~~6 mice~~ in the ~~5CLADBA JWH~~-~~210~~ (~~5 mg/kg, i.p~~.) ~~treated group showed loss of traction, of which 4 and 5 showed tremor, respectively~~. ~~Memory retention was measured after~~ the ~~memory acquisition was tested as a probe trial.<br>About Powder JWH~~-~~2<br><br>Figure 1. <br>Each training session lasted a maximum~~ of ~~10 min~~, ~~and~~ the ~~rats could earn up to 20 food pellets. Thirty minutes prior to~~ the ~~training sessions, rats received an injection~~ of ~~either vehicle or Δ9~~-~~THC and were subsequently placed in the behavior-testing chambers, where food~~ (45-~~mg food pellets; Bio~~-~~Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10~~) on a ~~designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling~~ and ~~was illuminated only when~~ the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, ~~TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks~~ of ~~age and maintained in~~ the ~~University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin<br><br>THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB)~~ and ~~ketamine are likely to become volatile under~~ the ~~temperature of current e-cigarettes, while crack cocaine is hard to vaporis~~<br><br><br>~~All of~~ the ~~compounds tested in the present study depressed locomotor activity as is typical~~ for ~~other synthetic cannabinoids (see review by Wiley et al~~.~~, 2017). Average horizontal activity counts/10 min~~ as ~~a function of time (10~~ min ~~bins) and dose~~. ~~Depressant effects of 1.33 mg/kg were observed within~~ 10 min ~~following administration and peak depressant effects~~ were ~~[https://cannabinoidsrc4f-adb~~.~~com/ 5CLADBA] observed between 0–30 min. Duration of the locomotor depression increased over dose from 30 min following 0.1 mg/kg to 2.5 h following 1 mg/k~~<br>~~<br><br>Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms~~ of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017<br><br>~~Fig. 2.~~ <br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender 5CLADBA and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>~~Victim B also brought "something resembling a drug"~~ (~~unrecognizable by Witness A) from his cousin (Witness B~~) in ~~a cigarette box and mixed this substance with their tobacco~~. The ~~half~~-~~maximal effective concentration (EC50)~~ of 4F-MDMB-BINACA is 5.~~69 nM~~ (~~2.76–11~~.0 nM) ~~on CB1,~~ and ~~0.69 nM~~ (0.~~30–1.56 nM) on CB2~~, in ~~vitro half-life~~ (~~t1/2~~) ~~is 10~~.~~27 min . It~~ is ~~usually available as~~ a ~~powder~~, ~~liquid~~ (~~vapor fluid)~~, ~~or herbal plant mixtur~~	+	High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the 5CLADBA presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom<br><br><br>The same procedure was then applied to the mice once every day for 5 days. It was considered as coordination disturbance when mice fell from the test apparatus within 2 min. Mice that remained their position on the running apparatus at 10 rpm for at least 2 min were selected for further evaluation.<br>Table of Conten<br><br><br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender [https://cannabinoidsrc4f-adb.com/ 5CLADBA] and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author<br><br><br>As synthetic cannabinoid receptor agonists (SCRA) are gaining popularity globally, clinicians have to understand that intoxication caused by vaping SCRA is not detected by commonly available tests. He confirmed that he had been vaping an electronic cigarette (e-cigarette) earlier that day just before the onset of his symptoms. Metabolic acidosis (1/3, 0/7) and respiratory acidosis (1/3, 0/7), All 10 patients recovered with supportive care, including intubation and ventilation for one case. In 3 cases ADB-BUTINACA was the only substance detected, while in seven other substances of misuse were also detected including other SCRA, opioids, benzodiazepines cocaine and pregabali<br><br>Legal status <br>Briefly, the FOB test was comprised of several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and death. The FOB test was performed using published procedures (Moser et al., 1989) with some modifications. However, because of their subjective properties, it is necessary to set up a more objective automated measurement to determine their neurotoxicity. However, there are only a couple of anecdotal reports suspecting the possibility of their neurotoxicity with no scientific evidence (Cohen et al., 2012; McGuinness and Newell, 2012; Harris and Brown, 2013; Hermanns et al., 2013